Dr. Todd M. Morgan shares key points from the AUA/ASTRO/SUO guideline on salvage therapy for prostate cancer. Todd 〽️ Morgan, MD Michigan Urology #pcsm #urology
urologytimes.com/view/prostate-…

Dr. Alexandra Tabakin gives an overview of a paper on recruiting and retaining diverse talent in urology. Allie Tabakin, MD Northwell Health #urology
urologytimes.com/view/dr-tabaki…

'When thinking about living with prostate cancer, this is really a couples' disease, and partners' unmet needs should be part of the conversation,' says Dr. Stacy Loeb. #pcsm #urology #urologist
urologytimes.com/view/new-tool-…

Dr. Brian Shuch and Dr. Neal Shore review clinical trials investigating new imaging options in kidney cancer, including the ZIRCON study looking at girentuximab. #kcsm #urology Brian Shuch, MD
urologytimes.com/view/overview-…

Investigators have identified key risk factors for non-susceptibility to antibiotics among patients with uncomplicated urinary tract infection. #urology
urologytimes.com/view/predictiv…

Dr. Angela Jia discusses the use of metastasis directed radiation therapy for patients with prostate cancer. #pcsm Angela Jia University Hospitals Urology Institute RadOncUH
urologytimes.com/view/dr-jia-on…

Dr. Raveen Syan recaps 2 sessions from #AUA24 on urodynamics in the context of the VALUE trial and implantable percutaneous tibial nerve stimulation devices. Raveen Syan, MD, FPMRS Desai Sethi Urology Institute #urology
urologytimes.com/view/dr-syan-r…

'We identified 12 discrete workflow steps for outpatient flexible cystoscopy, with 5 of those being able to be eliminated by the transition to the single-use scope,' says Dr. David Barquin. David Barquin Duke Urology Duke Urology Residency Program #urology
urologytimes.com/view/single-us…

Always love chatting with Urology Times about what amazing work our research team is doing

Interim data from a phase 1 trial showed a manageable safety profile and promising anti-tumor activity with the anti-CD70 CAR-NKT therapy CGC729 in patients with relapsed and refractory metastatic renal cell carcinoma. #kcsm #urology
urologytimes.com/view/anti-cd70…

Dr. Laura Bukavina discusses findings on the association between GLP1R agonists and genitourinary cancers. #pcsm #blcsm #kcsm Cleveland Clinic Urology
urologytimes.com/view/dr-bukavi…

'We do think that these data are reassuring & support the use of neuromodulation in a population who may have limited options otherwise,' says PGY4 resident, Dr. Leo Dreyfuss (Leo Dreyfuss), when discussing his study on sacral neuromodulation in nursing home residents.

Watch below⏬

The FDA has approved the study protocol for a phase 3 trial of LAE002 (an ANK inhibitor) in combination with LAE001 (a dual CYP17A1/CYP11B2 inhibitor) in patients with mCRPC. #pcsm #prostatecancer #urology
urologytimes.com/view/fda-green…

'I would say the take-home message is that usage of this mobile health platform could potentially improve patient quality of life and compliance with recommendations,' says Dr. Jenny Guo on an app for kidney stone prevention. Jenny Guo NM Urology
urologytimes.com/view/mobile-he…

“Cancer is a journey which is very emotional as much as it is physical. And not only for the patients, but it is also for their caregiver, whoever that person is,” say Joy Maulik, CRNP. Chesapeake Urology #urology
urologytimes.com/view/nurse-pra…

Dragonfly Therapeutics and Merck have entered into a clinical trial collaboration to evaluate the combination of DF9001 plus pembrolizumab in patients with advanced solid tumors, including renal cell carcinoma. #urology #kcsm
urologytimes.com/view/study-to-…

Dr. Vikram M. Narayan, MD discusses 5-year data on nadofaragene firadenovec in NMIBC. #AUA24 #blcsm Emory Urology
urologytimes.com/view/dr-naraya…

Investigators have developed a new tool that can be used to assess sexual health among female partners of patients with prostate cancer. Stacy Loeb, MD NYU Langone Urology NYU Grossman School of Medicine #pcsm #urology
urologytimes.com/view/new-tool-…

'What we saw among over 400 patients [was] that indeed, subcutaneous heparin did not increase the hematoma chance, but it reduced the chance to have venous thrombotic events,' says Dr. Thairo Pereira. #AUA24 Thairo Pereira Indiana University Department of Urology
urologytimes.com/view/study-sub…

'I think these findings suggest that for clinicians who treat a lot of older adults with neuromodulation, caution should be exhibited when recommending the single-stage approach,' says Dr. Leo Dreyfuss. Leo Dreyfuss Weill Cornell Medicine Urology #urology
urologytimes.com/view/single-st…